(Q36141107)

12 August 2017

1 reference

title

Sensitivity to stress: dysregulation of CRF pathways and disease development (English)

1 reference

12 August 2017

Tracy L Bale

1

1 reference

12 August 2017

publication date

17 March 2005

1 reference

12 August 2017

published in

Hormones and Behaviour

1 reference

12 August 2017

volume

48

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

1-10

1 reference

Amygdalar Participation in Tonic ACTH Secretion in the Rat

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Elevated CSF CRF in suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

The role of corticotropin-releasing factor in depression and anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

CRF and CRF receptors: role in stress responsivity and other behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Control of ACTH secretion by the central nucleus of the amygdala: implication of the serotoninergic system and its relevance to the glucocorticoid delayed negative feedback mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Regulation of ACTH secretion from corticotrophs: the interaction of vasopressin and CRF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

CRH-like peptides protect cardiac myocytes from lethal ischaemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Comparison of the biologic actions of corticotropin-releasing factor and sauvagine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Neuroendocrine pharmacology of stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Expression cloning of a human corticotropin-releasing-factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Targeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Molecular and biochemical characterization of the mouse brain corticotropin-releasing hormone-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Prenatal stress increases corticotropin-releasing factor (CRF) content and release in rat amygdala minces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Effect of blockade of corticotropin-releasing factor receptors in the median raphe nucleus on stress-induced c-fos mRNA in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail-pinch stressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Effects of Amygdaloid Lesions upon Septal Hyperemotionality in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Molecular Identification and Analysis of a Novel Human Corticotropin-Releasing Factor (CRF) Receptor: The CRF2 Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Role of the septum in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

The role of functional neuroimaging in the neuropsychology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CRF) by vasopressin in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Nature of ligand affinity and dimerization of corticotrophin-releasing factor-binding protein may be detected by circular dichroism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Regulation of the adrenocorticotrophin response to stress by the central nucleus of the amygdala in rats depends upon the nature of the stressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Effects of septal lesions on fear-potentiated startle, and on the anxiolytic effects of buspirone and diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

The role of corticotropin-releasing factor in the pathogenesis of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Neurobiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Are CRF receptor antagonists potential antidepressants?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Effect of chronic administration of a CRF(1) receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Expression and protective effects of urocortin in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Effects of corticotropin-releasing factor on brain serotonergic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Studies of the Nature of the Interaction between Vasopressin and Corticotropin-Releasing Factor on Adrenocorticotropin Release in the Rat*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Early developmental and temporal characteristics of stress-induced secretion of pituitary-adrenal hormones in prenatally stressed rat pups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Stressor controllability during pregnancy influences pituitary-adrenal hormone concentrations and analgesic responsiveness in offspring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Ontogeny of behavioral and hormonal responses to stress in prenatally stressed male rat pups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Prenatal stress potentiates stress-induced behavior and reduces the propensity to play in juvenile rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

The effects of early postnatal stimulation on Morris water-maze acquisition in adult mice: genetic and maternal factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Interactions of corticotropin-releasing factor with antidepressant and anxiolytic drugs: behavioral studies with pigeons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2005.01.009

10.1016/J.YHBEH.2005.01.009

7 January 2021

Identifiers

DOI

1 reference

release_jjrboo265rf3dkagq43lrfp7xe

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jjrboo265rf3dkagq43lrfp7xe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference